Mynd Healthcare

Report / Paper metadata

Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children.

A biomedical paper record. This page preserves its title, publication metadata and identifier, not the full article. The title alone does not establish the study findings or their clinical importance.

Limits

No clinical review has been performed. This record is not a treatment recommendation, eligibility confirmation or current availability guarantee.

Kind
Paper metadata

Worldwide health knowledge / Healthcare records